AzTrials
AzTrials

Cholecystectomy, LaparoscopicNCT05728073

Does Subtotal Cholecystectomy Rate for Acute Cholecystitis Change With a Previous ERCP?

An observational study of Cholecystectomy, Laparoscopic and Cholangiopancreatography, Endoscopic Retrograde, run by Bakirkoy Dr. Sadi Konuk Research and Training Hospital at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Study is designed to investigate whether the history of ERCP is associated with subtotal cholecystectomy rates in patients underwent laparoscopic cholecystectomy operations with the diagnosis of acute cholecystitis. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
ERCP
Type of treatment
Surgery or procedure
How many people
470 participants
Where
1 siteTurkey (Türkiye)
Study dates
10 Dec 2022to 25 Jan 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: - Patients operated with the diagnosis of acute cholecystitis a single center between January 2016 and December 2019.

Who may be able to join

  • Patients operated with the diagnosis of acute cholecystitis with an age greater or equal to 18 years old in a single center between January 2016 and December 2019

Who cannot join

  • Initial and direct preferance of open method
  • Being diagnosed with malignity after histopathological evaluation
  • Being operated just before one week after ERCP or after more than six weeks after ERCP

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Bakırkoy Dr.Sadi Konuk Training and Research Hospital

    Istanbul

Other trials in Turkey (Türkiye)

About this study

Study is designed to investigate whether the history of ERCP is associated with subtotal cholecystectomy rates in patients underwent laparoscopic cholecystectomy operations with the diagnosis of acute cholecystitis.

Read the detailed description

The results of patients who underwent surgery for acute cholecystitis in a single center between January 2016 and December 2019 were included and evaluated retrospectively.

Primary outcome was subtotal cholecystectomy rate. Secondary outcomes were conversion to open, complications and serious complications. Within examining demographic findings, operative records (rates for subtotal cholecystectomy and conversion to open, operative duration) and follow-up results (postoperative complications, serious complications, length of hospital stay and mortality) for all cases were investigated. Complications that Clavien-Dindo Score ≥ 3 accepted as serious complication. Intraoperative detection of gallbladder perforation was also noted and included in comparison. Any biliary tract complication that needed any percutaneous or endoscopic intervention to handle was named as "biliary leak" in the study.

Being tested
ERCP
Keywords
Acute Cholecystitis, Laparoscopic Subtotal Cholecystectomy
Medical subject headings
Cholecystitis, Acute

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ERCPProcedure or surgery

    Patients separated to two groups according to having a ERCP history before the operation

Study groups in NCT05728073
Study groupRoleWhat they receive
Standard (non-ERCP) GroupPatients who underwent surgery for acute cholecystitis without a previous ERCP history.
ERCP groupPatients who underwent surgery for acute cholecystitis with a previous ERCP history.
Receives: Procedure: ERCP

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Subtotal Cholecystectomy Rate

    Rate of patients needed subtotal cholecystectomy after initial intent of starting laparoscopic to the cholecystectomy

    Measured: Intraoperative

Secondary outcomes (1)
  1. Conversion to open

    Rate of patients needed conversion to open after initial intent of starting laparoscopic to the cholecystectomy

    Measured: Intraoperative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Feb 2023
  2. Study start10 Dec 2022
  3. Primary completion10 Jan 2023
  4. Study completion25 Jan 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Retrospective
Enrolment
470 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05728073
Sponsor's protocol ID
20230205
Status last verified
Sep 2023
First submitted
5 Feb 2023
Last updated
26 Sep 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Cholecystectomy, Laparoscopic and Cholangiopancreatography, Endoscopic Retrograde, run by Bakirkoy Dr. Sadi Konuk Research and Training Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Subtotal Cholecystectomy Rate (time frame: Intraoperative). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Sep 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in